These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1826013

  • 21. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
    Kelso A.
    J Immunol; 1990 Oct 01; 145(7):2167-76. PubMed ID: 1975827
    [Abstract] [Full Text] [Related]

  • 22. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ, Ronteltap CP, Gravekamp C, Monnikendam D, Bolhuis RL.
    J Immunol; 1986 Mar 01; 136(5):1700-7. PubMed ID: 3005399
    [Abstract] [Full Text] [Related]

  • 23. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR, Frey J, Takeshita T, Sugamura K.
    Eur Cytokine Netw; 1990 Mar 01; 1(1):27-34. PubMed ID: 2151685
    [Abstract] [Full Text] [Related]

  • 24. Anti-CD3-activated killer T cells: Interleukin-6 modulates the induction of major histocompatibility complex-unrestricted cytotoxicity and the expression of genes coding for cytotoxic effector molecules.
    Greene AL, Makrigiannis AP, Fitzpatrick L, Hoskin DW.
    J Interferon Cytokine Res; 1997 Dec 01; 17(12):727-37. PubMed ID: 9452360
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
    Botzler C, Kis K, Issels R, Multhoff G.
    Exp Hematol; 1997 Apr 01; 25(4):338-44. PubMed ID: 9131009
    [Abstract] [Full Text] [Related]

  • 27. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K, Salmeron MA, Kornbluth J, Bucana C, Itoh K.
    J Immunol; 1991 Apr 01; 146(7):2453-60. PubMed ID: 1900882
    [Abstract] [Full Text] [Related]

  • 28. IL-4 regulation of a protein kinase C independent pathway for the generation of alpha CD3-induced activated killer cells.
    Ting CC, Hargrove ME.
    Cell Immunol; 1992 Mar 01; 140(1):130-44. PubMed ID: 1531452
    [Abstract] [Full Text] [Related]

  • 29. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
    Pierres A, Naquet P, Van Agthoven A, Bekkhoucha F, Denizot F, Mishal Z, Schmitt-Verhulst AM, Pierres M.
    J Immunol; 1984 Jun 01; 132(6):2775-82. PubMed ID: 6202760
    [Abstract] [Full Text] [Related]

  • 30. Generation of cytolytic activity with anti-CD3 monoclonal antibodies involves both IL-2-independent and -dependent components.
    Stohl W, Tovar Z, Talal N.
    J Immunol; 1990 May 15; 144(10):3718-25. PubMed ID: 2139672
    [Abstract] [Full Text] [Related]

  • 31. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK, Doyle LV.
    J Immunol; 1989 Sep 15; 143(6):1761-7. PubMed ID: 2570801
    [Abstract] [Full Text] [Related]

  • 32. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L, Glass B, Zeis M, Dreger P, Steinmann J, Löffler H, Schmitz N.
    Exp Hematol; 1998 Feb 15; 26(2):93-9. PubMed ID: 9472798
    [Abstract] [Full Text] [Related]

  • 33. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 34. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS, Malek TR, Hargrove ME, Ting CC.
    J Immunol; 1985 Jun 15; 134(6):3912-9. PubMed ID: 3921614
    [Abstract] [Full Text] [Related]

  • 35. Functional consequences of cAMP accumulation in human natural killer cells. Implications for IL-2 and IL-4 signal transduction.
    Vitté-Mony I, Stancou R, Bertoglio JH.
    J Immunol; 1990 Dec 15; 145(12):4272-8. PubMed ID: 2175326
    [Abstract] [Full Text] [Related]

  • 36. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL, Roozemond RC, van de Griend RJ.
    J Immunol; 1986 Jun 01; 136(11):3939-44. PubMed ID: 3084649
    [Abstract] [Full Text] [Related]

  • 37. Phenotypic and functional analysis of murine CD3+,CD4-,CD8- TCR-gamma delta-expressing peripheral T cells.
    Cron RQ, Gajewski TF, Sharrow SO, Fitch FW, Matis LA, Bluestone JA.
    J Immunol; 1989 Jun 01; 142(11):3754-62. PubMed ID: 2523934
    [Abstract] [Full Text] [Related]

  • 38. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG, Holscher M, Urdal D.
    J Immunol; 1985 Aug 01; 135(2):1145-52. PubMed ID: 2409140
    [Abstract] [Full Text] [Related]

  • 39. Short-term ex vivo activation of splenocytes with anti-CD3 plus IL-2 and infusion post-BMT into mice results in in vivo expansion of effector cells with potent anti-lymphoma activity.
    Katsanis E, Xu Z, Anderson PM, Dancisak BB, Bausero MA, Weisdorf DJ, Blazar BR, Ochoa AC.
    Bone Marrow Transplant; 1994 Oct 01; 14(4):563-72. PubMed ID: 7858530
    [Abstract] [Full Text] [Related]

  • 40. Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity.
    Giovarelli M, Santoni A, Jemma C, Musso T, Giuffrida AM, Cavallo G, Landolfo S, Forni G.
    J Immunol; 1988 Oct 15; 141(8):2831-6. PubMed ID: 3139768
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.